Attached files

file filename
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - MEI Pharma, Inc.d303870ds1a.htm
EX-4.12 - FORM OF SUBSCRIPTION AGENT AGREEMENT - MEI Pharma, Inc.d303870dex412.htm
EX-23.1 - CONSENT OF BDO USA, LLP - MEI Pharma, Inc.d303870dex231.htm
EX-99.1 - FORM OF INSTRUCTIONS FOR USE OF RIGHTS CERTIFICATE AND SUBSCRIPTION FORM - MEI Pharma, Inc.d303870dex991.htm
EX-4.14 - FORM OF SUBSCRIPTION RIGHTS CERTIFICATE - MEI Pharma, Inc.d303870dex414.htm
EX-5.1 - FORM OF OPINION OF MORGAN, LEWIS & BOCKIUS, LLP - MEI Pharma, Inc.d303870dex51.htm
EX-99.3 - FORM OF LETTER TO BROKERS AND OTHER NOMINEE HOLDERS - MEI Pharma, Inc.d303870dex993.htm
EX-4.13 - FORM OF INFORMATION AGENT AGREEMENT - MEI Pharma, Inc.d303870dex413.htm
EX-4.15 - FORM OF WARRANT AGREEMENT - MEI Pharma, Inc.d303870dex415.htm
EX-23.2 - CONSENT OF BDO AUDIT (NSW-VIC) PTY LTD - MEI Pharma, Inc.d303870dex232.htm
EX-99.8 - INFORMATION FOR SUBSTITUTE FORM W-9 - MEI Pharma, Inc.d303870dex998.htm
EX-99.4 - FORM OF LETTER TO CLIENTS - MEI Pharma, Inc.d303870dex994.htm
EX-99.5 - FORM OF BENEFICIAL OWNER ELECTION FORM - MEI Pharma, Inc.d303870dex995.htm
EX-99.7 - FORM OF NOTICE OF GUARANTEED DELIVERY - MEI Pharma, Inc.d303870dex997.htm
EX-99.2 - FORM OF LETTER TO REGISTERED HOLDERS OF COMMON STOCK - MEI Pharma, Inc.d303870dex992.htm

Exhibit 99.6

FORM OF NOMINEE HOLDER CERTIFICATION

MARSHALL EDWARDS, INC.

SUBSCRIPTION RIGHTS FOR THE EXERCISE OF UNITS CONSISTING OF

UP TO AN AGGREGATE OF [            ] SHARES OF MARSHALL EDWARDS, INC. COMMON

STOCK AND WARRANTS FOR THE PURCHASE OF UP TO AN AGGREGATE OF [            ]

SHARES OF COMMON STOCK

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE PROSPECTUS OF

MARSHALL EDWARDS, INC., DATED [            ], 2012 (THE “PROSPECTUS”).

The undersigned, a broker, custodian bank, or other nominee holder (the “Nominee Holder”) of non-transferable subscription rights (the “Rights”) to purchase units (“Units”) consisting of shares of common stock, par value $0.00000002 per share (the “Common Stock”), and warrants to purchase additional shares of Common Stock of Marshall Edwards, Inc. (the “Company”) pursuant to the rights offering described and provided for in the Prospectus, hereby certifies to the Company, to Computershare, Inc., as subscription agent for the rights offering, and to Georgeson, Inc., as information agent for the rights offering, that the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), the Rights to purchase the number of Units specified below under the Basic Subscription Right (as defined in the Prospectus), and on behalf of beneficial owners of rights who have exercised their Basic Subscription Right in full (after giving effect to any permitted distributions, as described in the Prospectus), the request to purchase the number of additional Units specified below pursuant to the Over-subscription Privilege (as defined in the Prospectus), the terms of which are described further in the Prospectus, listing separately each exercised Basic Subscription Right and any corresponding Over-subscription Privilege as to each beneficial owner for whom the Nominee Holder is acting hereby:

 

Number of Shares Owned on

Record Date

 

Number of Units Subscribed For

Under Basic Subscription Right

 

Number of Units Requested

Under Over-subscription

Privilege

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Print Name of the Nominee Holder:                                                                                                                                           

By:                                                                                                                                                                                                         

Name:                                                                                                                                                                                                             

Title:                                                                                                                                                                                                     

Contact Phone Number:                                                                                                                                                                                

Provide the following information, if applicable:

 

 

Depository Trust Company (“DTC”) Participant Number


 

Participant

By:                                                                                                                                                                                                     

Name:                                                                                                                                                                                                

Title:                                                                                                                                                                                                   

Contact Phone Number: